- Home
- / The Medicines Company
The Medicines Company
Stock Price
$84.9
2020-01-06
Market Capitalization
$6.8 B
2020-01-06
Revenue
$6.1 M
FY, 2018
The Medicines Company Summary
Company Summary
- Overview
- The Medicines Company is a biopharmaceutical company. It focuses on the development of treatment for atherosclerotic cardiovascular disease. In addition, the Company specializes in three therapeutic areas: serious infectious disease care, cardiovascular care and surgery, perioperative care.
- Type
- Public
- Status
- Closed
- Founded
- 1996
- HQ
- Parsippany-Troy Hills, NJ, US | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
1 location detected
Parsippany-Troy Hills, NJ HQ
United States
8 Sylvan Way, Parsippany
The Medicines Company Financials
Summary Financials
- Net income (Q3, 2019)
- ($74.0M)
- Cash (Q3, 2019)
- $265.9M
- EBIT (Q3, 2019)
- ($61.4M)
- Enterprise value
- $6.9B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026